{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T16:59:38Z","timestamp":1780678778139,"version":"3.54.1"},"reference-count":43,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,6,1]],"date-time":"2018-06-01T00:00:00Z","timestamp":1527811200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,6,1]],"date-time":"2018-06-01T00:00:00Z","timestamp":1527811200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"name":"JSPS\/MEXT KAKENHI","award":["l19590604"],"award-info":[{"award-number":["l19590604"]}]},{"name":"JSPS\/MEXT KAKENHI","award":["23590761"],"award-info":[{"award-number":["23590761"]}]},{"DOI":"10.13039\/501100001700","name":"Ministry of Education, Culture, Sports and Science, Japan","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100001700","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001700","name":"MEXT","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001700","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009619","name":"AMED","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Innovative Drug Discovery and Life Science Research","award":["JP17am0101077"],"award-info":[{"award-number":["JP17am0101077"]}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Antiviral Research"],"published-print":{"date-parts":[[2018,6]]},"DOI":"10.1016\/j.antiviral.2018.04.011","type":"journal-article","created":{"date-parts":[[2018,4,14]],"date-time":"2018-04-14T11:46:32Z","timestamp":1523706392000},"page":"58-65","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"special_numbering":"C","title":["Human monoclonal antibodies against West Nile virus from Japanese encephalitis-vaccinated volunteers"],"prefix":"10.1016","volume":"154","author":[{"given":"Tatsuhiko","family":"Ozawa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hideyuki","family":"Masaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomohiko","family":"Takasaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3146-2171","authenticated-orcid":false,"given":"Ikuko","family":"Aoyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takahiro","family":"Yumisashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atsushi","family":"Yamanaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eiji","family":"Konishi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoh","family":"Ohnuki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1035-1977","authenticated-orcid":false,"given":"Atsushi","family":"Muraguchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroyuki","family":"Kishi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.antiviral.2018.04.011_bib1","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1038\/nature18938","article-title":"Structural basis of potent Zika-dengue virus antibody cross-neutralization","volume":"536","author":"Barba-Spaeth","year":"2016","journal-title":"Nature"},{"key":"10.1016\/j.antiviral.2018.04.011_bib2","doi-asserted-by":"crossref","first-page":"2431","DOI":"10.1128\/AAC.01178-09","article-title":"Safety and pharmacokinetics of single intravenous dose of MGAWN1, a novel monoclonal antibody to West Nile virus","volume":"54","author":"Beigel","year":"2010","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.antiviral.2018.04.011_bib3","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1086\/376870","article-title":"Prophylactic and therapeutic efficacy of human intravenous immunoglobulin in treating West Nile virus infection in mice","volume":"188","author":"Ben-Nathan","year":"2003","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.antiviral.2018.04.011_bib4","doi-asserted-by":"crossref","first-page":"2384","DOI":"10.3390\/v5102384","article-title":"Vaccines in development against West nile virus","volume":"5","author":"Brandler","year":"2013","journal-title":"Viruses"},{"key":"10.1016\/j.antiviral.2018.04.011_bib5","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1146\/annurev.micro.56.012302.160654","article-title":"The molecular biology of West Nile Virus: a new invader of the western hemisphere","volume":"56","author":"Brinton","year":"2002","journal-title":"Annu. Rev. Microbiol."},{"issue":"Pt 1","key":"10.1016\/j.antiviral.2018.04.011_bib6","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1099\/0022-1317-70-1-37","article-title":"Antigenic relationships between flaviviruses as determined by cross-neutralization tests with polyclonal antisera","volume":"70","author":"Calisher","year":"1989","journal-title":"J. Gen. Virol."},{"key":"10.1016\/j.antiviral.2018.04.011_bib7","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1111\/j.1600-065X.2008.00676.x","article-title":"The structural immunology of antibody protection against West Nile virus","volume":"225","author":"Diamond","year":"2008","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.antiviral.2018.04.011_bib8","series-title":"Antibody Engineering","first-page":"77","author":"Djavadi-Ohaniance","year":"1996"},{"key":"10.1016\/j.antiviral.2018.04.011_bib9","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/0022-1759(85)90044-4","article-title":"Measurements of the true affinity constant in solution of antigen-antibody complexes by enzyme-linked immunosorbent assay","volume":"77","author":"Friguet","year":"1985","journal-title":"J. Immunol. Methods"},{"key":"10.1016\/j.antiviral.2018.04.011_bib10","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1016\/j.micinf.2007.05.013","article-title":"Co-immunization with West Nile DNA and inactivated vaccines provides synergistic increases in their immunogenicities in mice","volume":"9","author":"Ishikawa","year":"2007","journal-title":"Microbes Infect."},{"key":"10.1016\/j.antiviral.2018.04.011_bib11","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1038\/nprot.2011.322","article-title":"Rapid isolation of antigen-specific antibody-secreting cells using a chip-based immunospot array","volume":"6","author":"Jin","year":"2011","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.antiviral.2018.04.011_bib12","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1038\/nm.1966","article-title":"A rapid and efficient single-cell manipulation method for screening antigen-specific antibody-secreting cells from human peripheral blood","volume":"15","author":"Jin","year":"2009","journal-title":"Nat. Med."},{"key":"10.1016\/j.antiviral.2018.04.011_bib13","doi-asserted-by":"crossref","first-page":"11000","DOI":"10.1128\/JVI.01735-06","article-title":"Crystal structure of west nile virus envelope glycoprotein reveals viral surface epitopes","volume":"80","author":"Kanai","year":"2006","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2018.04.011_bib14","doi-asserted-by":"crossref","first-page":"311","DOI":"10.3201\/eid0903.020628","article-title":"Experimental infection of north American birds with the New York 1999 strain of West Nile virus","volume":"9","author":"Komar","year":"2003","journal-title":"Emerg. Infect. Dis."},{"key":"10.1016\/j.antiviral.2018.04.011_bib15","doi-asserted-by":"crossref","first-page":"4864","DOI":"10.1128\/JVI.00252-16","article-title":"Zika virus: new clinical syndromes and its emergence in the western hemisphere","volume":"90","author":"Lazear","year":"2016","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2018.04.011_bib16","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.bbrc.2010.03.175","article-title":"Post-translational modification of TRAIL receptor type 1 on various tumor cells and the susceptibility of tumors to TRAIL-induced apoptosis","volume":"395","author":"Lin","year":"2010","journal-title":"Biochem. Biophys Res. Commun."},{"key":"10.1016\/j.antiviral.2018.04.011_bib17","doi-asserted-by":"crossref","first-page":"S98","DOI":"10.1038\/nm1144","article-title":"Emerging flaviviruses: the spread and resurgence of Japanese encephalitis, West Nile and dengue viruses","volume":"10","author":"Mackenzie","year":"2004","journal-title":"Nat. Med."},{"key":"10.1016\/j.antiviral.2018.04.011_bib18","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1051\/vetres\/2010039","article-title":"West Nile virus and its emergence in the United States of America","volume":"41","author":"Murray","year":"2010","journal-title":"Vet. Res."},{"key":"10.1016\/j.antiviral.2018.04.011_bib19","doi-asserted-by":"crossref","first-page":"11467","DOI":"10.1128\/JVI.01125-06","article-title":"Crystal structure of the West Nile virus envelope glycoprotein","volume":"80","author":"Nybakken","year":"2006","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2018.04.011_bib20","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1038\/nature03956","article-title":"Structural basis of West Nile virus neutralization by a therapeutic antibody","volume":"437","author":"Nybakken","year":"2005","journal-title":"Nature"},{"key":"10.1016\/j.antiviral.2018.04.011_bib21","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1007\/BF01314119","article-title":"Rapid focus reduction neutralization test of Japanese encephalitis virus in microtiter system. Brief report","volume":"86","author":"Okuno","year":"1985","journal-title":"Arch virol"},{"key":"10.1016\/j.antiviral.2018.04.011_bib22","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1517\/14712598.7.6.885","article-title":"The molecular basis of antibody-mediated neutralization of West Nile virus","volume":"7","author":"Oliphant","year":"2007","journal-title":"Expert Opin. Biol. Ther."},{"key":"10.1016\/j.antiviral.2018.04.011_bib23","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1038\/nm1240","article-title":"Development of a humanized monoclonal antibody with therapeutic potential against West Nile virus","volume":"11","author":"Oliphant","year":"2005","journal-title":"Nat. Med."},{"key":"10.1016\/j.antiviral.2018.04.011_bib24","doi-asserted-by":"crossref","first-page":"11828","DOI":"10.1128\/JVI.00643-07","article-title":"Induction of epitope-specific neutralizing antibodies against West Nile virus","volume":"81","author":"Oliphant","year":"2007","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2018.04.011_bib25","doi-asserted-by":"crossref","first-page":"12149","DOI":"10.1128\/JVI.01732-06","article-title":"Antibody recognition and neutralization determinants on domains I and II of West Nile Virus envelope protein","volume":"80","author":"Oliphant","year":"2006","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2018.04.011_bib26","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.antiviral.2011.06.012","article-title":"Characterization of a fully human monoclonal antibody against extracellular domain of matrix protein 2 of influenza A virus","volume":"91","author":"Ozawa","year":"2011","journal-title":"Antivir. Res."},{"issue":"469\u2013470","key":"10.1016\/j.antiviral.2018.04.011_bib27","first-page":"472","article-title":"Amplification and analysis of cDNA generated from a single cell by 5'-RACE: application to isolation of antibody heavy and light chain variable gene sequences from single B cells","volume":"40","author":"Ozawa","year":"2006","journal-title":"BioTechniques"},{"key":"10.1016\/j.antiviral.2018.04.011_bib28","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0052383","article-title":"A novel rabbit immunospot array assay on a chip allows for the rapid generation of rabbit monoclonal antibodies with high affinity","volume":"7","author":"Ozawa","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.antiviral.2018.04.011_bib29","doi-asserted-by":"crossref","first-page":"434","DOI":"10.4269\/ajtmh.2008.78.434","article-title":"Serologic diagnosis of West Nile and St. Louis encephalitis virus infections in domestic chickens","volume":"78","author":"Patiris","year":"2008","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"10.1016\/j.antiviral.2018.04.011_bib30","doi-asserted-by":"crossref","first-page":"173","DOI":"10.7326\/0003-4819-137-3-200208060-00009","article-title":"West Nile virus: a primer for the clinician","volume":"137","author":"Petersen","year":"2002","journal-title":"Ann. Intern Med."},{"key":"10.1016\/j.antiviral.2018.04.011_bib31","first-page":"175","article-title":"Cross-reactivity of human monoclonal antibodies generated with peripheral blood lymphocytes from dengue patients with Japanese encephalitis virus","volume":"7","author":"Pipattanaboon","year":"2013","journal-title":"Biologics"},{"key":"10.1016\/j.antiviral.2018.04.011_bib32","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/S0065-3527(03)59005-4","article-title":"Antigenic structure of flavivirus proteins","volume":"59","author":"Roehrig","year":"2003","journal-title":"Adv. Virus Res."},{"key":"10.1016\/j.antiviral.2018.04.011_bib33","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1038\/nature14130","article-title":"Recognition determinants of broadly neutralizing human antibodies against dengue viruses","volume":"520","author":"Rouvinski","year":"2015","journal-title":"Nature"},{"key":"10.1016\/j.antiviral.2018.04.011_bib34","doi-asserted-by":"crossref","first-page":"9557","DOI":"10.1128\/JVI.00080-06","article-title":"Cryptic properties of a cluster of dominant flavivirus cross-reactive antigenic sites","volume":"80","author":"Stiasny","year":"2006","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2018.04.011_bib35","doi-asserted-by":"crossref","first-page":"650","DOI":"10.4049\/jimmunol.0900093","article-title":"Fusion loop peptide of the West Nile virus envelope protein is essential for pathogenesis and is recognized by a therapeutic cross-reactive human monoclonal antibody","volume":"183","author":"Sultana","year":"2009","journal-title":"J. Immunol."},{"key":"10.1016\/j.antiviral.2018.04.011_bib36","doi-asserted-by":"crossref","first-page":"4514","DOI":"10.1016\/S0264-410X(03)00507-3","article-title":"Partial protective effect of inactivated Japanese encephalitis vaccine on lethal West Nile virus infection in mice","volume":"21","author":"Takasaki","year":"2003","journal-title":"Vaccine"},{"key":"10.1016\/j.antiviral.2018.04.011_bib37","doi-asserted-by":"crossref","first-page":"11333","DOI":"10.1038\/srep11333","article-title":"Production of monoclonal antibodies against GPCR using cell-free synthesized GPCR antigen and biotinylated liposome-based interaction assay","volume":"5","author":"Takeda","year":"2015","journal-title":"Sci. Rep."},{"key":"10.1016\/j.antiviral.2018.04.011_bib38","doi-asserted-by":"crossref","first-page":"6982","DOI":"10.1128\/JVI.00551-06","article-title":"Isolation and characterization of human monoclonal antibodies from individuals infected with West Nile Virus","volume":"80","author":"Throsby","year":"2006","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2018.04.011_bib39","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1586\/14760584.6.2.183","article-title":"Mapping and analysis of West Nile virus-specific monoclonal antibodies: prospects for vaccine development","volume":"6","author":"Throsby","year":"2007","journal-title":"Expert Rev. Vaccines"},{"key":"10.1016\/j.antiviral.2018.04.011_bib40","doi-asserted-by":"crossref","first-page":"6494","DOI":"10.1128\/JVI.00286-09","article-title":"Human monoclonal antibodies against West Nile virus induced by natural infection neutralize at a postattachment step","volume":"83","author":"Vogt","year":"2009","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2018.04.011_bib41","doi-asserted-by":"crossref","first-page":"654","DOI":"10.3201\/eid0704.017409","article-title":"Clinical findings of West Nile virus infection in hospitalized patients, New York and New Jersey, 2000","volume":"7","author":"Weiss","year":"2001","journal-title":"Emerg. Infect. Dis."},{"key":"10.1016\/j.antiviral.2018.04.011_bib42","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0156716","article-title":"AGIA tag system based on a high affinity rabbit monoclonal antibody against human dopamine receptor D1 for protein analysis","volume":"11","author":"Yano","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.antiviral.2018.04.011_bib43","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1086\/599794","article-title":"Development of resistance to passive therapy with a potently neutralizing humanized monoclonal antibody against West Nile virus","volume":"200","author":"Zhang","year":"2009","journal-title":"J. Infect. Dis."}],"container-title":["Antiviral Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166354217308537?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166354217308537?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T12:27:27Z","timestamp":1759062447000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0166354217308537"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,6]]},"references-count":43,"alternative-id":["S0166354217308537"],"URL":"https:\/\/doi.org\/10.1016\/j.antiviral.2018.04.011","relation":{},"ISSN":["0166-3542"],"issn-type":[{"value":"0166-3542","type":"print"}],"subject":[],"published":{"date-parts":[[2018,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Human monoclonal antibodies against West Nile virus from Japanese encephalitis-vaccinated volunteers","name":"articletitle","label":"Article Title"},{"value":"Antiviral Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.antiviral.2018.04.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}